Biocare Medical
Chris Gildea has a diverse work experience in various roles and responsibilities. Starting in 2005, they began their career at BD, where they worked in multiple positions, including Manufacturing Associate, Sales Specialist, District Sales Manager, and Product Manager. In 2011, they became the US Channel Manager for Domestic Distribution and later served as the US Channel Manager for Fisher & VWR.
In 2012, they joined Corning Life Sciences as the US Channel Manager for Discovery Labware Brands. The following year, they joined WHEATON Industries as the Director of Sales for Chromatography Consumables. Chris was later promoted to Vice President of Sales for Glass & Plastic Consumables.
In 2016, they transitioned to BD once again, holding the positions of WW Senior Director of Global Marketing for the Pen Needle Franchise and WW Senior Director of Global Sales Effectiveness.
Since 2019, Chris has been working at Biocare Medical, initially as the Chief Commercial Officer, responsible for leading strategic and tactical marketing, global sales, and sales operations organization. Chris was later promoted to Chief Strategy Officer and currently holds the role of CFO & Chief Strategy Officer as of 2023.
Chris Gildea has a Bachelor of Science degree in Biology from Quinnipiac University. Additionally, they obtained a Master of Business Administration degree in Marketing from Rutgers University - Camden.
This person is not in any offices
Biocare Medical
Biocare Medical is an innovator in developing and supplying world class automated immunohistochemistry instrumentation, and the full range of reagents for IHC lab testing. Biocare is the market leader in simultaneous Multiplex IHC tests which provide increased confidence at critical diagnostic decision points, impacting patient therapy whileaccelerating turnaround time. Biocare’s advanced micro-polymer™ detection enables unsurpassed specificity and sensitivity. PROMARK™ and “mouse on mouse” IHC detection kits are optimized for rat and mouse tissues and feature proprietary blocking and retrieval reagents, resulting in virtually background free IHC staining.The company’s customers include clinical histology laboratories, pharmaceutical companies, CROs, and biotechnology companies as well as academic, government, military, and other non-profit laboratories. Biocare Medical offers an expanding portfolio of integrated products to address the rapidly growing cancer and infectious disease diagnostic and research markets with novel tissue immunohistochemistry and in situ hybridization methods. Biocare medical is headquartered and has manufacturing facilities in Concord, Calif., and has a global distribution network.